Everi Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Everi in the last year. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Everi stock.
View analyst ratings for Everi or view top-rated stocks.

5 Wall Street research analysts have issued 1 year target prices for Everi's shares. Their EVRI stock forecasts range from $30.00 to $35.00. On average, they expect Everi's stock price to reach $31.25 in the next twelve months. This suggests a possible upside of 88.5% from the stock's current price.
View analysts' price targets for Everi or view top-rated stocks among Wall Street analysts.

Everi's stock was trading at $21.35 at the start of the year. Since then, EVRI shares have decreased by 22.3% and is now trading at $16.58.
View the best growth stocks for 2022 here.

Everi is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Everi.

Everi Holdings Inc. (NYSE:EVRI) posted its earnings results on Tuesday, May, 10th. The credit services provider reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.03. The credit services provider had revenue of $175.60 million for the quarter, compared to the consensus estimate of $169.38 million. Everi had a net margin of 23.52% and a trailing twelve-month return on equity of 98.81%. Everi's revenue was up 26.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.21 EPS.
View Everi's earnings history.

75 employees have rated Everi CEO Michael D. Rumbolz on Glassdoor.com. Michael D. Rumbolz has an approval rating of 84% among Everi's employees.

Some companies that are related to Everi include Visa (V), Mastercard (MA), Automatic Data Processing (ADP), Fiserv (FISV), Fidelity National Information Services (FIS), Paychex (PAYX), Global Payments (GPN), Broadridge Financial Solutions (BR), FLEETCOR Technologies (FLT), Jack Henry & Associates (JKHY), Genpact (G), WEX (WEX), Western Union (WU), Euronet Worldwide (EEFT) and ExlService (EXLS).
View all of EVRI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Everi investors own include Inovio Pharmaceuticals (INO), Matinas BioPharma (MTNB), OrganiGram (OGI), New Residential Investment (NRZ), General Electric (GE), ADMA Biologics (ADMA), Dynavax Technologies (DVAX), Chesapeake Energy (CHKAQ), Sorrento Therapeutics (SRNE) and Nokia Oyj (NOK).

Everi trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVRI."

Everi's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Capital Research Global Investors (8.42%), BlackRock Inc. (6.32%), Vanguard Group Inc. (5.92%), Eagle Asset Management Inc. (5.10%), Gilder Gagnon Howe & Co. LLC (2.33%) and Emerald Advisers LLC (2.22%). Company insiders that own Everi stock include Darren Simmons, David Lucchese, Dean A Ehrlich, Eileen F Raney, Geoffrey P Judge, Harper H Ko, Linster W Fox, Mark F Labay, Maureen T Mullarkey, Michael D Rumbolz, Randy L Taylor, Ronald V Congemi and Todd A Valli.
View institutional ownership trends for Everi.

EVRI stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Capital Research Global Investors, Vanguard Group Inc., Emerald Mutual Fund Advisers Trust, Arrowstreet Capital Limited Partnership, Bank of New York Mellon Corp, First Trust Advisors LP, and BlackRock Inc.. Company insiders that have sold Everi company stock in the last two years include Darren Simmons, David Lucchese, Dean A Ehrlich, Eileen F Raney, Geoffrey P Judge, Linster W Fox, Mark F Labay, Michael D Rumbolz, Randy L Taylor, Ronald V Congemi, and Todd A Valli.
View insider buying and selling activity for Everi or view top insider-selling stocks.

EVRI stock was purchased by a variety of institutional investors in the last quarter, including Cardinal Capital Management LLC CT, AGF Investments Inc., Invesco Ltd., Calamos Advisors LLC, Ziegler Capital Management LLC, Emerald Advisers LLC, Millrace Asset Group Inc., and Russell Investments Group Ltd..
View insider buying and selling activity for Everi or or view top insider-buying stocks.

Shares of EVRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EVRI stock can currently be purchased for approximately $16.58.

Everi (NYSE:EVRI) has a market capitalization of $1.53 billion and generates $660.39 million in revenue each year. The credit services provider earns $152.93 million in net income (profit) each year or $1.62 on an earnings per share basis.

Everi employs 1,550 workers across the globe.

Everi's mailing address is 7250 S. Tenaya Way Suite 100, Las Vegas NV, 89113. The official website for Everi is www.everi.com. The credit services provider can be reached via phone at (800) 833-7110, via email at [email protected], or via fax at 866-672-4371.